| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 06/30/1993 | EP0548790A1 (1'S)-Hydroxyalkyloxapenem-3-carboxylic acids and their use as beta-lactamase inhibitors |
| 06/30/1993 | EP0548680A1 Beta-oxo-beta-benzenepropanethioamide derivatives |
| 06/30/1993 | EP0548664A1 2,3,3a-5,9b-hexahydro-1H-benzo(e)indole derivatives |
| 06/30/1993 | EP0548635A1 Pharmaceutical compositions of roxindol or carmoxirol with pregelatinized starch |
| 06/30/1993 | EP0548595A2 Pharmaceutical system for the administration of controlled release therapeutically active dihydropyridines, and method to produce it |
| 06/30/1993 | EP0548448A1 Stabilized controlled release substrate having a coating derived from an aqueous dispersion of hydrophobic polymer |
| 06/30/1993 | EP0548406A1 Therapeutic use of ganglioside GM1 in the treatment of spinal cord injury |
| 06/30/1993 | EP0548370A1 Drug for preventing and/or treating allergic disease |
| 06/30/1993 | EP0548357A1 Treatment of hair loss and dermatological problems |
| 06/30/1993 | EP0548345A1 Pharmaceutical compositions |
| 06/30/1993 | EP0548327A1 2,14-disubstituted ergolines, their production and use in medicaments |
| 06/30/1993 | EP0548314A1 Use of a 2-deoxystreptamine-type antibiotic |
| 06/30/1993 | EP0548291A1 Pyridylthio or pyridyloxy alkanoic acids |
| 06/30/1993 | EP0548254A1 6- or 7- (2-IMINO-2-IMIDAZOLIDINE)-1,4-BENZOXAZINES AS ALPHA ADRENERGIC AGENTS |
| 06/30/1993 | EP0548238A1 Non-aqueous liquid oral suspensions |
| 06/30/1993 | EP0548235A1 Synthetic drug molecules that mimic metalloenzymes |
| 06/30/1993 | EP0548227A1 Compounds |
| 06/30/1993 | EP0548226A1 Monosaccharides having anti-proliferation and anti-inflammatory activity, compositions and uses thereof |
| 06/30/1993 | EP0548168A1 Imidazole derivatives, their preparation and pharmaceutical compositions |
| 06/30/1993 | EP0548145A1 Topical treatment and composition |
| 06/30/1993 | EP0548125A1 Substituted 6,7-dihydroimidazo(1,5,4-ef)(1,5)benzodiazepin-6-ones, their preparation and pharmaceutical compositions |
| 06/30/1993 | EP0548110A1 Soluble melanin |
| 06/30/1993 | EP0548103A1 Use of pyridylmethylsulphinyl-1h-benzimidazole derivates in the treatment of illnesses caused by helicobacter bacteria |
| 06/30/1993 | EP0542864A4 Treatment for hypercholesterolemia |
| 06/30/1993 | EP0455631B1 Preparation containing salicylic acid for treating desquamative skin diseases |
| 06/30/1993 | EP0404807B1 Deprenyl for systemic transdermal administration |
| 06/30/1993 | EP0343223B1 Use of melatonin or derivatives thereof for the production of pharmaceutical compositions effective to counteract the effects of aging |
| 06/30/1993 | CN1073683A Organic salts of N,N'-diacetyl cystine |
| 06/30/1993 | CN1073677A 20-methyl-substituted vitamin D-derivatives |
| 06/30/1993 | CN1073599A Acanthopanax giraldii harms polysaccharose and preparation method of its pharmaceutics |
| 06/30/1993 | CN1021454C Method of stimulating animal growing |
| 06/30/1993 | CN1021445C Process for preparation of steroids including a spiro ring in position 17 |
| 06/30/1993 | CN1021444C Process for preparation of 16, 17-acetalsubstituted androstane-17 beta-carboxylic acid esters |
| 06/30/1993 | CN1021442C Process for preparation of thiopyranodipyrazoles |
| 06/30/1993 | CN1021441C Process for preparation of new benzamides |
| 06/29/1993 | USRE34299 Psychological disorders, neuroleptic agents, analgesics |
| 06/29/1993 | US5223612 Process for the preparation of benzothiazepines by cyclization with phosphonic acids |
| 06/29/1993 | US5223541 Tramadol n-oxide material, enantiomers and compositions thereof, and their use |
| 06/29/1993 | US5223540 Fluvoxamine |
| 06/29/1993 | US5223538 Protecting cells against free radicals by treatment with hydroxamate-type siderophore chelate compounds and manganese compounds |
| 06/29/1993 | US5223537 Method and composition for treatment of gastric and duodenal disorders |
| 06/29/1993 | US5223533 Antiallergens, antiinflammatory, sunscreen agents |
| 06/29/1993 | US5223531 1,3,2-dioxathiolan-s-oxide derivatives, method for preparation, and use therefor |
| 06/29/1993 | US5223529 N-phenylamides and medicinal products containing them |
| 06/29/1993 | US5223525 Pesticidal 1-arylimidazoles |
| 06/29/1993 | US5223521 Pyrazole and thiozole derivatives for treatment of gastrointestinal ulcer disease |
| 06/29/1993 | US5223519 4-hydroxypyridine derivatives, useful for treating circulatory diseases |
| 06/29/1993 | US5223517 Heterocyclically substituted cycloalkano[b]-indolesulphonamides |
| 06/29/1993 | US5223515 Injectable solution containing a pyridyl methylsulfinylbenzimidazole |
| 06/29/1993 | US5223513 Quinoline derivatives, their production and use |
| 06/29/1993 | US5223510 Alkylaminoalkyl derivatives of benzofuran, benzothiophene, indole and indolizine, process for their preparation and compositions containing them |
| 06/29/1993 | US5223507 Method of using opioid compounds as delta opioid selective agonist analgesics |
| 06/29/1993 | US5223505 For cardiovascular disorders; modulating sino-arial node action |
| 06/29/1993 | US5223504 Xanthine compounds and compositions, and methods of using them |
| 06/29/1993 | US5223501 Substituted pyrimidinones bearing acidic functional groups as angiotensin ii antagonists |
| 06/29/1993 | US5223499 6-amino substituted imidazo[4,5-bipyridines as angiotensin II antagonists |
| 06/29/1993 | US5223498 Phenylamidine and phenylguanidine derivatives and their use as antidiabetic agents |
| 06/29/1993 | US5223497 Treating habit disorders |
| 06/29/1993 | US5223494 Orally administered porphyrins to control intestinal iron absorption |
| 06/29/1993 | US5223493 Anti-inflammatory compounds for ophthalmic use |
| 06/29/1993 | US5223490 Treating breast cancer |
| 06/29/1993 | US5223481 Biologically active lipoprotein and its use |
| 06/29/1993 | US5223271 Lithium treatment |
| 06/29/1993 | US5223268 Improved bioavailability |
| 06/29/1993 | US5223263 Viricide complex; aids therapy |
| 06/29/1993 | US5223261 Transdermal estradiol delivery system |
| 06/29/1993 | US5223258 Antiviral disinfecting composition and method of inactivating the aids virus in vitro |
| 06/29/1993 | US5223257 Topical composition for relieving aches and pains |
| 06/29/1993 | US5223248 Non-antibacterial tetracycline compositions possessing antiplaque properties |
| 06/29/1993 | CA1319697C2 Enantioselective process for producing 1-.beta.-methylcarbapenem antibiotic intermediates |
| 06/29/1993 | CA1319695C Substituted 1,3,4,9-tetrahydropyrano¬3,4-b|- indole-1-acetic acids |
| 06/29/1993 | CA1319694C 4-oxo-7-substituted hydroxy-4h-benzopyrane derivatives |
| 06/29/1993 | CA1319692C 2-methoxycarbonyl substituted n, n' -di-(trimethoxybenzoyl) piperazines, process for preparing the same and therapeutical compounds containing them |
| 06/29/1993 | CA1319688C 5,6,7,8-tetrahydro-4h-isoxazolo [4,5-c] azepine derivatives |
| 06/29/1993 | CA1319687C 5-substituted 10-cyanomethylenethieno [3,4-b] benzazepines |
| 06/29/1993 | CA1319684C Ergolinyl compounds nitrogen-substituted in the 8- position, their preparation, and use as medicinal agents |
| 06/29/1993 | CA1319682C Process for the preparation of new oximes derivated from 7-aminothiazolylacetamidocephalosporanic acid |
| 06/29/1993 | CA1319681C Platinum derivatives and cancer treatments |
| 06/29/1993 | CA1319680C Synthesis of 6-methylene derivatives of androsta-1,4-diene-3,17-dione |
| 06/29/1993 | CA1319636C Process for the production of macrolide compounds |
| 06/29/1993 | CA1319616C Long-acting diclofenac sodium preparation |
| 06/29/1993 | CA1319615C Method of preparing a solid composition of lactulose, and composition so obtained |
| 06/29/1993 | CA1319605C Virucidal agent having wide-spectrum activity |
| 06/28/1993 | CA2086213A1 Pyridylthiazolidinecarboxylic acid amide derivatives, their preparation and their therapeutic uses |
| 06/28/1993 | CA2085844A1 Fused benzeneoxyacetic acid derivatives |
| 06/28/1993 | CA2085427A1 2-saccharinylmethyl and 4,5,6,7-tetrahydro-2-saccharinylmethyl phosphates, phosphonates and phosphinates useful as proteolytic enzyme inhibitors and compositions and method of usethereof |
| 06/28/1993 | CA2058502A1 2-amino-mono-methoxycyclohexyl amides useful as analgesics |
| 06/27/1993 | CA2086277A1 Thiazolidine compounds, their preparation and their therapeutic uses |
| 06/27/1993 | CA2086210A1 .beta.-oxo-.beta.-benzenepropanethioamide derivatives |
| 06/27/1993 | CA2086026A1 Bisphosphonate derivative |
| 06/27/1993 | CA2075346A1 Blocking induction of tetrahydrobiopterin to block induction of nitric oxide synthesis |
| 06/25/1993 | WO1993012806A1 A method for the treatment of tumours and sarcomas |
| 06/25/1993 | CA2086160A1 Use of n-substituted n-phenylsulfonylurea in the treatment of high blood pressure in insulion-resistant subjects |
| 06/25/1993 | CA2085954A1 Substituted pyridine n-oxides, processes for their preparation, and their use |
| 06/24/1993 | WO1993013070A1 Process for preparing flunixin and intermediates thereof |
| 06/24/1993 | WO1993013056A1 Stable salts of (+)-(1s,2r)-2-[[n-(2-hydroxylamino-2-oxoethyl)-n-methyl-amino]carbonyl]cyclohexane-1-carboxylic acid, process for their preparation and pharmaceutical compositions containing them |
| 06/24/1993 | WO1993012251A1 Senescent cell derived inhibitors of dna synthesis |
| 06/24/1993 | WO1993012240A1 Gene therapy for cystic fibrosis transmembrane conductance regulator activity (cftr) |
| 06/24/1993 | WO1993012221A1 Association between a human immunodeficiency virus-related retrovirus and autoimmune disease |
| 06/24/1993 | WO1993012138A1 Compounds and compositions for treating hiv infections |